Geron Corporation

GERN

$0.997

Name : Geron Corporation

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $642,048,448.00

EPSttm : -0.08

Geron Corporation

$0.997

2.29%

$0.023

GERN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.54

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

EPS Last/This Y

0.11

EPS This/Next Y

0.11

Price

Target Price

3.5

Analyst Recom

1.4

Performance Q

-33.55

Upside

-340.2%

Beta

0.6

Ticker: GERN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	GERN	1.205	0.28	10.79	73173
2026-10-14	GERN	1.185	0.28	0.05	73593
2026-10-15	GERN	1.225	0.28	0.77	73909
2026-10-16	GERN	1.175	0.28	0.02	74059
2026-10-19	GERN	1.195	0.29	0.06	70256
2026-10-20	GERN	1.23	0.29	0.10	70313
2026-10-21	GERN	1.15	0.29	0.04	70337
2026-10-22	GERN	1.125	0.28	0.11	71121
2026-10-23	GERN	1.115	0.28	0.26	71309
2026-10-26	GERN	1.15	0.28	0.17	71774
2026-10-27	GERN	1.14	0.28	0.19	71982
2026-10-28	GERN	0.9659	0.28	0.53	72114
2026-10-29	GERN	0.9415	0.29	0.60	74184
2026-10-30	GERN	0.8931	0.29	0.16	74330
2026-11-02	GERN	0.9295	0.27	0.02	75086
2026-11-03	GERN	0.9367	0.27	0.09	75738
2026-11-04	GERN	1.075	0.27	0.05	76021
2026-11-05	GERN	0.9501	0.27	0.00	76271
2026-11-06	GERN	0.9878	0.27	0.06	76308
2026-11-09	GERN	0.9905	0.27	0.29	76246
2026-11-10	GERN	0.9719	0.27	0.00	76285
2026-11-11	GERN	1.005	0.27	0.01	76119
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	GERN	1.21	66.7	63.9	-0.02
2026-10-14	GERN	1.19	66.7	64.1	-0.02
2026-10-15	GERN	1.23	66.7	65.2	-0.02
2026-10-16	GERN	1.17	66.7	62.9	-0.02
2026-10-19	GERN	1.20	66.7	65.0	-0.02
2026-10-20	GERN	1.20	66.7	65.0	-0.02
2026-10-21	GERN	1.24	66.7	65.8	-0.02
2026-10-22	GERN	1.12	66.7	63.8	-0.02
2026-10-23	GERN	1.12	66.7	63.8	-0.02
2026-10-26	GERN	1.15	66.7	65.8	-0.02
2026-10-27	GERN	1.14	66.7	64.6	-0.02
2026-10-28	GERN	0.97	66.7	58.9	-0.02
2026-10-29	GERN	0.95	66.7	63.7	-0.02
2026-10-30	GERN	0.89	66.7	62.4	-0.02
2026-11-02	GERN	0.93	-	66.0	-0.04
2026-11-03	GERN	0.94	-	66.3	-0.04
2026-11-04	GERN	1.08	-	70.1	-0.04
2026-11-05	GERN	0.95	-	43.0	-0.04
2026-11-06	GERN	0.99	-	47.6	-0.04
2026-11-09	GERN	0.99	-	46.2	-0.04
2026-11-10	GERN	0.97	-	45.3	-0.04
2026-11-11	GERN	1.00	-	47.3	-0.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	GERN	0.00	-0.14	11.67
2026-10-14	GERN	0.00	-0.14	11.67
2026-10-15	GERN	0.00	-0.14	11.67
2026-10-16	GERN	0.00	-0.14	11.67
2026-10-19	GERN	0.00	-0.17	11.67
2026-10-20	GERN	0.00	-0.17	11.67
2026-10-21	GERN	0.00	-0.17	11.67
2026-10-22	GERN	0.00	-0.17	11.67
2026-10-23	GERN	0.00	-0.17	11.67
2026-10-26	GERN	0.00	-0.77	11.67
2026-10-27	GERN	0.00	-0.77	11.78
2026-10-28	GERN	0.00	-0.77	11.78
2026-10-29	GERN	0.00	-0.77	11.78
2026-10-30	GERN	0.00	-0.77	11.78
2026-11-02	GERN	0.00	-0.92	11.78
2026-11-03	GERN	0.00	-0.92	11.78
2026-11-05	GERN	0.00	-0.92	11.78
2026-11-06	GERN	0.00	-0.92	11.78
2026-11-09	GERN	0.00	-1.60	11.75
2026-11-10	GERN	0.00	-1.60	11.75
2026-11-11	GERN	0.00	-1.60	10.54
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.01

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

Institutional Transactions

-1.6

Beta

0.6

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.3

Max Drawdown 5-Year %

-82.4

Target Price

3.5

P/E

Forward P/E

14.17

PEG

P/S

3.02

P/B

2.9

P/Free Cash Flow

EPS

-0.07

Average EPS Est. Cur. Y

-0.02

EPS Next Y. (Est.)

0.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-23.04

Relative Volume

0.54

Return on Equity vs Sector %

-47.5

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

47.3

◆ GERN Healthcare

$1.02

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

11/15

Valuation

15/20

TP/AR

4/10

Options

8/10

RSI

44.3

Range 1M

38.8%

Sup Dist

8.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

25/30

Estimates

4/20

Inst/Vol

0/15

Options

8/10

EPS Yr

78.5%

EPS NY

357.1%

52W%

13.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +218.6% upside

Quality

6/30

Valuation

18/30

Growth

18/25

Stability

5/10

LT Trend

1/5

Upside

+218.6%

Quality

GERN — P/E HistoricalBiotechnology

Geron Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 258

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

GERN

Latest News

—

Caricamento notizie per GERN…

stock quote shares GERN – Geron Corporation Stock Price stock today

news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GERN – Geron Corporation yahoo finance google finance

stock history GERN – Geron Corporation invest stock market

stock prices GERN premarket after hours

ticker GERN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GERN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y